Philip Oyer

Dr. Gregory W. Albers is a distinguished stroke and vascular neurologist based in Palo Alto, California, serving as the Coyote Foundation Professor and Director of the Stanford Stroke Center. With extensive education and board certifications in neurology and vascular neurology, he is recognized for his contributions to the field through numerous publications and clinical research. At Stanford Health Care, Dr. Albers specializes in advanced treatments for stroke and related neurological conditions, emphasizing innovative approaches and patient-centered care. His commitment to research and education enhances the quality of care provided to patients, making him a leading figure in the realm of neurology. Generated from the website

The Stanford Neurocritical Care Program at Stanford Health Care provides specialized care for patients experiencing critical neurological illnesses. With a team of fellowship-trained neurocritical care specialists, the program emphasizes advanced diagnostics, multimodality monitoring, and comprehensive treatment plans tailored to each patient's needs. Recognized as the nation's first Comprehensive Stroke Center and a Level 1 Trauma Center, Stanford's neurocritical care team delivers high-quality care for complex, life-threatening neurological conditions. Their expertise encompasses various advanced neuroimaging techniques and neuromonitoring capabilities, ensuring that critically ill patients receive pioneering treatment in a hybrid suite designed for efficiency and safety. Generated from the website

Dr Joy Wu is Chief of the Division of Endocrinology and Vice Chair of Basic Science in the Department of Medicine at Stanford. She is a board-certified endocrinologist who specializes in treating osteoporosis and other bone and mineral diseases. She has a special interest in optimizing skeletal health for those at risk of bone loss from glucocorticoid treatment, cancer therapies, or organ transplant. She has served on expert panels and guideline committees for the American Society for Transplantation and Cellular Therapy, the American Society of Clinical Oncology, and the Endocrine Society. Dr. Wu also directs a basic and translational research program that focuses on skeletal development and the bone marrow hematopoietic niche.